Tocilizumab in acute necrotizing encephalopathy (ANE): How much, how soon, and will it improve outcomes beyond survival?

Eur J Paediatr Neurol. 2024 Sep:52:A3-A4. doi: 10.1016/j.ejpn.2024.08.010. Epub 2024 Sep 4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Humans
  • Leukoencephalitis, Acute Hemorrhagic* / drug therapy
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab